Search

Search Constraints

You searched for: Author/Creator Sano, Takayuki

Search Results

1. Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer. Issue 1 (24th September 2021)

3. Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy. Issue 6 (20th January 2023)